7Baggers
 Could GLTO Become the Next Big Pharma Star?​  StocksToTrade Tue, 23 Sep 2025 14:03:00 GMT
 galecto inc. shares surge: is it too late to hop on?  timothysykes.com Tue, 23 Sep 2025 13:19:00 GMT
 Morning Market Movers: SLE, GLTO, SSKN, IPDN See Big Swings  RTTNews Tue, 23 Sep 2025 11:58:00 GMT
 published on: 2025-09-11 19:13:31  Newser Fri, 12 Sep 2025 00:13:31 GMT
 published on: 2025-09-08 09:05:31  Newser Mon, 08 Sep 2025 14:05:31 GMT
 published on: 2025-09-03 03:26:49  Newser Wed, 03 Sep 2025 08:26:49 GMT

Galecto, Inc
(NASDAQ:GLTO) 

GLTO stock logo

Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of sever...

Founded: 2011
Full Time Employees: 23
CEO: Hans Thalsgård Schambye  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends